By: Leslie Peppers

Leslie Peppers — Fri, 01 Nov 2024 02:33:50 +0000

Pharmaceutical companies, in my opinion, work together to control the lives of citizens of what is supposed to be a free country. Here is one of the reasons for my opinion.
Robert M. Califf MD is the Commissioner of the FDA. He was nominated by President Obama to head the FDA in 2016 and renominated by President Biden in 2021. He worked very closely with pharmaceutical companies at the Duke clinical trials center “convincing them to do large, expensive, and profitable clinical trials.” He was a paid consultant for six pharma companies from 2009 to 2013. The largest consulting payment was $87,500 by Johnson & Johnson in 2012, and “most of funds for travel or consulting under were $5,000”, which has been called “minimal for a physician of his stature”. From 2013 to 2014 he was paid a total of $52,796; the greatest amount being $6,450 from Merck Sharp & Dohme, followed by Amgen, F. Hoffmann-La Roche AG, Janssen Pharmaceutica, Daiichi Sankyo, Sanofi-Aventis, Bristol-Myers Squibb and AstraZeneca. He was a director of Portola Pharmaceuticals, Inc. from July 2012 to January 26, 2015, an advisor for Proventys, Inc., chairman of the medical advisory board of Regado Biosciences, Inc. and has been a member of that board since June 2, 2009 and a member of the clinical advisory board of Corgentech Inc. Forbes wrote that his close ties to the drug industry were why he was not nominated for the FDA Commissioner position in 2009. Califf’s ties to the pharmaceutical industry were criticized by the magazine The American Prospect and Democratic Senators Bernie Sanders and Joe Manchin, who announced their intention to vote against his 2021 renomination. Last but not least, he is a major stockholder in several pharma companies that have made him a multimillionaire. Natural health solutions cut his profits.

Comments on: FDA Poses Ban on Sex Drive Hormone and Green Tea Amino Acid

By: Leslie Peppers